10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies
10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies
Stay updated with breaking news from Willfully Infringed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies
/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that a jury in the U.S. District Court for the...
Jury Awards 10x Genomics Over $31 Million in Damages and Finds All Seven Asserted Patents Valid and Willfully Infringed by NanoString GeoMx Decision is Third Ruling Against NanoString, Showing...
This week in Other Barks & Bites: the FTC files an amicus brief asking an appeals court to reconsider an antitrust case against pharmaceutical companies who paid generic manufacturers to drop their patent disputes; senators introduce a bill that would eliminate judicial exceptions to patent eligibility; and more.